Our Toronto office and Belmore Neidrauer LLP have successfully defended Gilead Sciences Inc. before the Supreme Court of Canada.
April 26, 2018
Our Montreal office acted for I-MED Pharma Inc. in defence to TearLab Corporation's action for infringement of its patent pertaining to a tear osmolarity measuring system.
February 13, 2018
Our Toronto office represented and obtained intervention status for Innovative Medicines Canada before the Supreme Court of Canada in the hearing of AstraZeneca Canada Inc. et al v. Apotex Inc., involving AstraZeneca’s appeal on the invalidation of its patent for NEXIUM (esomeprazole) for lacking patented utility.
June 30, 2017
Try searching our global site instead